Dr. Sanjay Kalra, MD

Dr. Kalra practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Kalra's NPI, 1407836422, was assigned on January 17, 2006. Dr. Kalra holds Minnesota license 38626.

Dr. Kalra's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Kalra's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Kalra to 1 more hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalra practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kalra's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Kalra is licensed in Minnesota.

CMS data shows 163 Medicare services from Dr. Kalra across 7 procedure codes in 2024, for 154 Medicare patients. Medicare paid $16,161 for them.

CMS counts 154 Medicare patients who saw Dr. Kalra in 2024. The largest group is 75 to 84, with 67 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kalra's median patient age at 71, with 53% women.

In 2024, Dr. Kalra wrote 450 Medicare Part D claims for 110 patients. 54% of them were for generic drugs. CMS names the drug for 318 of them, across 11 drugs with 11 or more claims each, at $629,743 in total drug cost. In 2023, CMS named 190 claims across 8 drugs.

Dr. Kalra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kalra as offering telehealth.

Dmand AI links 1,056 papers to Dr. Kalra, published from 2010 to 2025. 2023 was the busiest year, with 52. The most frequent topics are Diabetes Mellitus, Diabetes Mellitus, Type 2 and Hypoglycemic Agents. Dr. Kalra has published most often in J Pak Med Assoc. Dr. Kalra's most frequent co-authors are Nitin Kapoor, Manisha Sahay, MD and Vijay Viswanathan, MD.

Dmand AI links Dr. Kalra to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Diabetes Mellitus, Type 1, Spastic Paraplegia, Hereditary and Autoimmune Diseases.

CMS Open Payments shows 7 general payments to Dr. Kalra from 3 drug and device companies from 2016 to 2021. Consulting fees make up the largest share, 87% of the total. Boston Scientific Corporation paid the most, $2,275.